LONDON: Syncona’s portfolio company, Achilles Therapeutics has announced that it expects to consider additional capital raising options this year, which could include an initial public offering in the United States. The timing and the terms of any such offering have not yet been determined and are subject to market conditions and other factors. There is … Continue reading Syncona’s Achilles announces additional financing plans including IPO in USA